Search all trials

Find therapies in clinical trials near you – page 144

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Factor IX deficiency

Recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of Etranacogene Dezaparvovec Gene Therapy for Adults with Severe or Moderately Severe Hemophilia B and AAV5 Antibodies

Registered drugNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:Etranacogene Dezaparvovec

Contact Research Centre

Cardiovascular disorder

Recruiting

Registered drug

Study on Colchicine and Aspirin for Improving Heart Health in Adults with Type 2 Diabetes Without Previous Heart Events

Registered drug

Denmark

Participants:18–64 years · 65+ years
Substances:Carbasalate Calcium

Contact Research Centre

Sickle cell disease

Recruiting

Investigational

Study on How Well Etavopivat Works for Adolescents and Adults with Sickle Cell Disease

Investigational

Belgium

Participants:0–17 years · 18–64 years · 65+ years
Substances:Etavopivat

Contact Research Centre

Study on Eltrombopag for Treating Low and Intermediate Risk Myelodysplastic Syndromes in Patients with Thrombocytopenia

Recruiting

Registered drugNo placebo

Study on Eltrombopag for Treating Low and Intermediate Risk Myelodysplastic Syndromes in Patients with Thrombocytopenia

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Eltrombopag

Contact Research Centre

Dermatomyositis+2

Recruiting

Registered drugNo placebo

Study on the Long-Term Safety of Dazukibart in Patients with Idiopathic Inflammatory Myopathies, Including Dermatomyositis and Polymyositis

Registered drugNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:Azathioprine

Contact Research Centre

Fibrodysplasia ossificans progressiva

Recruiting

Registered drugNo placebo

Study on the Safety of Intradermal mRNA COVID-19 Vaccine Bretovameran for Patients with Fibrodysplasia Ossificans Progressiva

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years

Contact Research Centre

Prostate cancer

Recruiting

Registered drugNo placebo

Study of 99mTc-MIP-1404 SPECT/CT imaging compared to standard imaging methods for detecting lymph node metastases in patients with prostate cancer

Registered drugNo placebo

Finland

Participants:18–64 years · 65+ years
Substances:Piflufolastat (18F)

Contact Research Centre

Metabolic dysfunction-associated steatohepatitis

Recruiting

InvestigationalNo placebo

Study on Liver Fibrosis Assessment Using 68Ga-FAPI-46 Imaging in Patients with Suspected or Confirmed Nonalcoholic Steatohepatitis

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:(S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate

Contact Research Centre

Type 2 diabetes mellitus

Recruiting

Registered drugNo placebo

Study on Using Dapagliflozin, Semaglutide, and Finerenone to Prevent Heart and Kidney Complications in Patients with Type 2 Diabetes

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Dapagliflozin

Contact Research Centre

Systemic scleroderma

Recruiting

InvestigationalNo placebo

Study on the Safety of T-Guard (Dafsolimab Setaritox, Grisnilimab Setaritox) for Patients with Early Diffuse Cutaneous Systemic Sclerosis

InvestigationalNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:GRISNILIMAB SETARITOX

Contact Research Centre

Age-related macular degeneration

Recruiting

Registered drugNo placebo

Study on Treating Neovascular Age-Related Macular Degeneration with Aflibercept, Ranibizumab, and Brolucizumab for Patients with Active Disease

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Aflibercept

Contact Research Centre

Psoriasis

Recruiting

Registered drugNo placebo

Study on Sodium Fluoride (18F) PET-CT Scans for Detecting Bone Changes in Psoriasis Patients at Risk of Psoriatic Arthritis

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Sodium Fluoride (18F)

Contact Research Centre

Find therapies in clinical trials near you – page 144

10 246 trials match your criteria

Factor IX deficiency

Study on the Safety and Effectiveness of Etranacogene Dezaparvovec Gene Therapy for Adults with Severe or Moderately Severe Hemophilia B and AAV5 Antibodies

Cardiovascular disorder

Study on Colchicine and Aspirin for Improving Heart Health in Adults with Type 2 Diabetes Without Previous Heart Events

Sickle cell disease

Study on How Well Etavopivat Works for Adolescents and Adults with Sickle Cell Disease

Study on Eltrombopag for Treating Low and Intermediate Risk Myelodysplastic Syndromes in Patients with Thrombocytopenia

Study on Eltrombopag for Treating Low and Intermediate Risk Myelodysplastic Syndromes in Patients with Thrombocytopenia

Dermatomyositis+2

Study on the Long-Term Safety of Dazukibart in Patients with Idiopathic Inflammatory Myopathies, Including Dermatomyositis and Polymyositis

Fibrodysplasia ossificans progressiva

Study on the Safety of Intradermal mRNA COVID-19 Vaccine Bretovameran for Patients with Fibrodysplasia Ossificans Progressiva

Prostate cancer

Study of 99mTc-MIP-1404 SPECT/CT imaging compared to standard imaging methods for detecting lymph node metastases in patients with prostate cancer

Metabolic dysfunction-associated steatohepatitis

Study on Liver Fibrosis Assessment Using 68Ga-FAPI-46 Imaging in Patients with Suspected or Confirmed Nonalcoholic Steatohepatitis

Type 2 diabetes mellitus

Study on Using Dapagliflozin, Semaglutide, and Finerenone to Prevent Heart and Kidney Complications in Patients with Type 2 Diabetes

Systemic scleroderma

Study on the Safety of T-Guard (Dafsolimab Setaritox, Grisnilimab Setaritox) for Patients with Early Diffuse Cutaneous Systemic Sclerosis

Age-related macular degeneration

Study on Treating Neovascular Age-Related Macular Degeneration with Aflibercept, Ranibizumab, and Brolucizumab for Patients with Active Disease

Psoriasis

Study on Sodium Fluoride (18F) PET-CT Scans for Detecting Bone Changes in Psoriasis Patients at Risk of Psoriatic Arthritis

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.